搜索
礼来
LLY添加自选
1208.120USD
+79.000+7.01%
收盘 06/26, 16:00（美东）报价延迟15分钟
1.14T总市值
42.84市盈率 TTM
关于 礼来 公司
礼来公司是全球知名的创新药物巨头，专注于在人用医药领域的研发、制造与销售。其糖尿病、肥胖及心脏代谢线代表药品含 Basaglar、Humalog、Mounjaro、Trulicity 与 Zepbound（体重管理）；肿瘤产品涵盖 Alimta、Retevmo、Tyvyt、Verzenio；免疫学阵容包含 Ebglyss、Olumiant、Omvoh、Taltz；神经科学线提供 Cymbalta、Emgality；其他重点品牌及疗法尚有 Cialis、Forteo。公司透过 POINT Biopharma 深耕放射性药物研发，并开发 α4β7 抑制剂 MORF-057 治疗 IBD，同时投资 AI 药物设计与数字临床平台以加速候选药上市。
礼来简介
公司代码LLY
公司名称Eli Lilly and Co
上市日期Jul 09, 1970
CEORicks (David A)
员工数量47000
证券类型Ordinary Share
年结日Jul 09
公司地址Lilly Corporate Ctr
城市INDIANAPOLIS
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编46285
电话13172762000
网址https://www.lilly.com/
公司代码LLY
上市日期Jul 09, 1970
CEORicks (David A)
礼来公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Anne E. White
Ms. Anne E. White
Executive Vice President, President - Lilly Neuroscience
Executive Vice President, President - Lilly Neuroscience
74.21K
+11.64%
Mr. Patrik Jonsson
Mr. Patrik Jonsson
Executive Vice President, President of Lilly Cardiometabolic Health and President, Lilly USA
Executive Vice President, President of Lilly Cardiometabolic Health and President, Lilly USA
61.12K
+11.45%
Ms. Anat Hakim
Ms. Anat Hakim
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
55.56K
+53.81%
Mr. Edgardo Hernandez
Mr. Edgardo Hernandez
Executive Vice President, President - Manufacturing Operations
Executive Vice President, President - Manufacturing Operations
46.10K
+13.81%
Mr. Ilya Yuffa
Mr. Ilya Yuffa
Executive Vice President, President of Lilly International
Executive Vice President, President of Lilly International
29.80K
-8.39%
Mr. Diogo Rau
Mr. Diogo Rau
Executive Vice President, Chief Information and Digital Officer
Executive Vice President, Chief Information and Digital Officer
26.40K
+25.30%
Dr. Katherine Baicker, Ph.D.
Dr. Katherine Baicker, Ph.D.
Independent Director
Independent Director
23.54K
+0.70%
Mr. Lucas E. Montarce
Mr. Lucas E. Montarce
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
16.26K
+9.66%
Mr. Eric Dozier
Mr. Eric Dozier
Executive Vice President, Chief People Officer
Executive Vice President, Chief People Officer
14.46K
+31.93%
Ms. Kimberly H. Johnson
Ms. Kimberly H. Johnson
Independent Director
Independent Director
3.27K
+0.67%
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Anne E. White
Ms. Anne E. White
Executive Vice President, President - Lilly Neuroscience
Executive Vice President, President - Lilly Neuroscience
74.21K
+11.64%
Mr. Patrik Jonsson
Mr. Patrik Jonsson
Executive Vice President, President of Lilly Cardiometabolic Health and President, Lilly USA
Executive Vice President, President of Lilly Cardiometabolic Health and President, Lilly USA
61.12K
+11.45%
Ms. Anat Hakim
Ms. Anat Hakim
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
55.56K
+53.81%
Mr. Edgardo Hernandez
Mr. Edgardo Hernandez
Executive Vice President, President - Manufacturing Operations
Executive Vice President, President - Manufacturing Operations
46.10K
+13.81%
Mr. Ilya Yuffa
Mr. Ilya Yuffa
Executive Vice President, President of Lilly International
Executive Vice President, President of Lilly International
29.80K
-8.39%
Mr. Diogo Rau
Mr. Diogo Rau
Executive Vice President, Chief Information and Digital Officer
Executive Vice President, Chief Information and Digital Officer
26.40K
+25.30%
常见问题
礼来的前五大股东是谁？
礼来 的前五大股东如下：Ms. Anne E. White
有多少机构持有礼来(LLY)的股份？
截至2026Q1，共有6331家机构持有礼来的股份，合计持有的股份价值约为864.16M，占公司总股份的91.72%。与2025Q4相比，机构持股有所增加，增幅为69007266.00。
哪个业务部门对礼来的收入贡献最大？
在2026Q1，Diabetes-Mounjaro业务部门对礼来的收入贡献最大，创收6.52B，占总收入的37.02%。
